Trial site
Lombardi Comprehensive Cancer Center, Georgetown University
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Pancreatic cancer3 trials
- Liver and biliary tract cancer2 trials
- Multiple myeloma2 trials
- Prostate cancer1 trial
- Thymoma and thymic carcinoma1 trial
- Phase
- Phase 210 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Withdrawn3 trials
- Terminated2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Georgetown University10 trials
- Hackensack Meridian Health3 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Active, not recruiting
MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer
Active, not recruiting
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
Active, not recruiting
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
Closed trials
Withdrawn
Withdrawn
Terminated
Withdrawn
Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026